ALNY – Alnylam Pharmaceuticals, Inc. –

  • Quotes
  • Charts

News & Analysis for ALNY

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Files An 8-K Other Events

ME Staff 8-k -
0

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Files An 8-K Entry into a Material...

ME Staff 8-k -
0

Analyst Activity – Evercore ISI Initiates Coverage On Alnylam Pharmaceuticals (NASDAQ:ALNY)...

ME Staff -
0

Analyst Activity – Evercore ISI Initiates Coverage On Alnylam Pharmaceuticals (NASDAQ:ALNY)...

ME Staff -
0

Analyst Activity – JMP Securities Raises Its Price Target On Alnylam...

ME Staff -
0

Analyst Activity – Credit Suisse Group Raises Its Price Target On...

ME Staff -
0

Analyst Activity – B. Riley Lowers Its Price Target On Alnylam...

ME Staff -
0

Analyst Activity – Morgan Stanley Lowers Its Price Target On Alnylam...

ME Staff -
0

Alnylam Pharmaceuticals (NASDAQ:ALNY) reported earnings of ($1.48) per share missing Walls...

ME Staff -
0

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Files An 8-K Results of Operations and...

ME Staff 8-k -
0

Affimed, Alnylam Are End Of The Week Movers In Biotech

ME Contributor -
0

Analyst Activity – Leerink Swann Raises Its Price Target On Alnylam...

ME Staff -
0

Analyst Activity – Chardan Capital Reiterates Buy on Alnylam Pharmaceuticals (NASDAQ:ALNY)

ME Staff -
0

Here’s What’s Moving Aclaris Therapeutics, Inc. (NASDAQ:ACRS) And Alnylam Pharmaceuticals, Inc....

ME Contributor -
0

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Files An 8-K Entry into a Material...

ME Staff 8-k -
0

Biotech Movers: Ocera Therapeutics, Inc. (NASDAQ:OCRX) and Alnylam Pharmaceuticals, Inc. (Nasdaq:...

ME Contributor -
0

Analyst Upgrades – Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Gets Upgraded By Goldman...

ME Staff -
0
DelMar

Here Are Two Phase II Trials To Watch: Alnylam Pharmaceuticals, Inc....

ME Contributor -
0
Load more